Nowadays the diagnosis of HCV infection is based on the detection of anti-HCV antibodies (HCV-Ab) subsequently confirmed by a RIBA test and HCV-RNA test.A new chemiluminescence assay is now available allowing the detection of HCV antigen (HCV-Ag) (HCV-Ag,Abbott, USA ® ).The aim of the study was to investigate the diagnostic performances of this new test.We performed on 63 selected serum samples the following analyses: HCV-Ab , HCV-Ag, RIBA test and HCV-RNA . For HCV-Ag vs HCV-RNA we found specificity of 95% and sensitivity of 100%. Our study has highlighted the diagnostic accuracy of HCV-Ag test. This test does not require special equipments to be performed, so its strong specificity suggests its possible role in a rapid and low-cost new diagnostic protocol, particularly in a population with low incidence of HCV infection.
BACKGROUND
Hepatitis C virus (HCV) is a major public health issue and a leading cause of chronic liver disease. The World Health Organization (WHO, 2009 ) estimates that about 200 milion people (about 3% of the world's population) are infected with HCV and 3 to 4 milion persons are newly infected each year. Moreover, at least 85% of infected persons become chronically infected and about 70% develop chronic hepatitis. The diagnosis of HCV infection in clinical practice, usually performed on asymptomatic patients, is carried out by detection of HCV antibodies (HCV-Ab) followed by confirmatory testing with additional HCV-Ab tests and/or HCV RNA detection (1). This procedure generate high numbers of false-positive results, increasing test time and costs per patient (2) . The aim of this study was to evaluate the role of HCV Ag assay (3) in a rapid and less-expensive diagnostic protocol ( Figure I) .
MATERIALS AND METHODS
The study was carried out on 63 selected samples; among these patients, 14 samples showed a potential interfering factors such as Rheumatoid Factor, HBsAg, Syfilide, HIV, IgM Toxoplasmosi, IgM Citomegalovirus and Epstein Barr Virus ( Table 1) 
RESULTS
HCV-Ag showed a specificity of 95% and a sensitivity of 100% with a predictive positive value (PPV) of was 92% and a predictive negative value (PNV) of 100%, compared to HCV-RNA Moreover, HCV-Ab presents a specificity of 24% and a sensitivity of 100% with a PPV of 46% and a PNV of 100%, compared to HCV-RNA (Table 2 ). 
CONCLUSIONS
In our study, we assessed the accuracy of HCV-Ag test for the diagnosis of HCV infection. Our preliminary data suggest that the HCV-Ag test is a rapid, less expensive and easy to perform assay. Combination of a high sensitive test (HCV-Ab) with a specific assay (HCV-Ag) could offer a rapid (less than one hour) and safe diagnostic protocol.
To reduce overestimation (false-positive) of HCV infection due to HCV-Ab, we propose to detect HCV-Ag in combination with HCV-Ab in all samples performed in routine clinical practice. As suggested in Figure II , a patient with HCV-Ag-positive/ HCV-Ab-negative is affected by an acute infection, so we can clarify the viral load by HCV RNA. On the other hand, in a patient with HCV-Ag-positive/HCV-Ab-positive we can conclude that it is a serological picture of HCV infection. In this case HCV RNA detection is useful to understand only the thorny cases, such as "grey-zone" reactivity. This new diagnostic algorithm can reduce the molecular-biology investigation tests with a high cost-effectiveness. 
